Gilead Sciences
GILD56
$107.56arrow_drop_up0.67%$0.72
S&P500
GILD56
$107.56
arrow_drop_up0.67%Performance History
| Key Stats | |
|---|---|
| Open | $105.85 |
| Prev. Close | $106.74 |
| EPS | 0.38 |
| Next Earnings Date | Jun 24, 2025 |
| LOW | HIGH | |
|---|---|---|
| Day Range | 105.36 | 107.60 |
| 52 Week Range | 62.07 | 119.91 |
| Ratios | |
|---|---|
| EPS | 0.38 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Gilead Sciences (GILD)
- Sector
- Healthcare
- Industry
- Drug Manufacturers—General
- CEO
- Mr. Daniel P. O'Day
- Headquarters
- Foster City
- Employees
- 17000
- Exchange
- NASDAQ
Keep an eye on Gilead Sciences
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Gilead Sciences 's (GILD) price per share?
The current price per share for Gilead Sciences (GILD) is $107.57. The stock has seen a price change of $0.73 recently, indicating a 0.68% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Gilead Sciences (GILD)?
For Gilead Sciences (GILD), the 52-week high is $119.92, which is 11.48% from the current price. The 52-week low is $62.07, the current price is 73.3% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Gilead Sciences (GILD) a growth stock?
Gilead Sciences (GILD) has shown an average price growth of -1.65% over the past three years. It has received a score of 80 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Gilead Sciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Gilead Sciences (GILD) stock price performance year to date (YTD)?
As of the latest data, Gilead Sciences (GILD) has a year-to-date price change of 16.45%. Over the past month, the stock has experienced a price change of 1.95%. Over the last three months, the change has been -3.12%. Over the past six months, the figure is 19.27%. Looking at a longer horizon, the five-year price change stands at 46.67%.
help
Is Gilead Sciences (GILD) a profitable company?
Gilead Sciences (GILD) has a net income of $480M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 0.27% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 33.36% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $28.75B, with a revenue growth rate of 6.04%, providing insight into the company's sales performance and growth. The gross profit is $78.2M. Operating income is noted at $1.66B. Furthermore, the EBITDA is $10.72B.
help
What is the market capitalization of Gilead Sciences (GILD)?
Gilead Sciences (GILD) has a market capitalization of $124.82B. The average daily trading volume is 106.6, indicating the stock's liquidity and investor engagement.